{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:12Z","timestamp":1787729412162,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1124\/jpet.115.224121","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T02:00:03Z","timestamp":1437012003000},"page":"484-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs"],"prefix":"10.1016","volume":"354","author":[{"given":"Nathan M.","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyson H.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane B.","family":"Acri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.224121_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.110.167619","article-title":"Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys","volume":"334","author":"Achat-Mendes","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.224121_bib2","first-page":"145","article-title":"The peripheral dopaminergic system: morphological analysis, functional and clinical applications","volume":"107","author":"Amenta","year":"2002","journal-title":"Ital J Anat Embryol"},{"key":"10.1124\/jpet.115.224121_bib3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1096\/fj.13-243840","article-title":"Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation","volume":"28","author":"Armando","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/jpet.115.224121_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/cphy.c100032","article-title":"Dopamine and renal function and blood pressure regulation","volume":"1","author":"Armando","year":"2011","journal-title":"Compr Physiol"},{"key":"10.1124\/jpet.115.224121_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/syn.10188","article-title":"Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats","volume":"48","author":"Ashby","year":"2003","journal-title":"Synapse"},{"key":"10.1124\/jpet.115.224121_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI3685","article-title":"Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension","volume":"102","author":"Asico","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.224121_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1461145705006449","article-title":"Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat","volume":"10","author":"Cervo","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.115.224121_bib8","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.224121_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.vascn.2013.04.008","article-title":"A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions","volume":"68","author":"Ewart","year":"2013","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.115.224121_bib10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-013-3254-y","article-title":"The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats","volume":"231","author":"Galaj","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.115.224121_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/syn.20152","article-title":"Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors","volume":"57","author":"Gilbert","year":"2005","journal-title":"Synapse"},{"key":"10.1124\/jpet.115.224121_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semdp.2008.12.001","article-title":"Cocaine: history, social implications, and toxicity: a review","volume":"26","author":"Goldstein","year":"2009","journal-title":"Semin Diagn Pathol"},{"key":"10.1124\/jpet.115.224121_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2014.03.055","article-title":"The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats","volume":"569","author":"Hachimine","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.115.224121_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00210-012-0803-6","article-title":"Rationale in support of the use of selective dopamine D\u2083 receptor antagonists for the pharmacotherapeutic management of substance use disorders","volume":"386","author":"Heidbreder","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.115.224121_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","article-title":"The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence","volume":"49","author":"Heidbreder","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1124\/jpet.115.224121_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","article-title":"Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders","volume":"1187","author":"Heidbreder","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.115.224121_bib17","doi-asserted-by":"crossref","first-page":"e74116","DOI":"10.1371\/journal.pone.0074116","article-title":"The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis","volume":"8","author":"Johnson","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.224121_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuropharm.2005.04.022","article-title":"The dopamine D3 receptor and drug dependence: effects on reward or beyond?","volume":"49","author":"Le Foll","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.224121_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543784.16.1.45","article-title":"Dopamine D3 receptor ligands for the treatment of tobacco dependence","volume":"16","author":"Le Foll","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/jpet.115.224121_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0924-9338(00)00219-4","article-title":"Dopamine D3 receptor agents as potential new medications for drug addiction","volume":"15","author":"Le Foll","year":"2000","journal-title":"Eur Psychiatry"},{"key":"10.1124\/jpet.115.224121_bib21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3565(25)10235-8","article-title":"[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study","volume":"264","author":"Levant","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.224121_bib22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1124\/jpet.115.224121_bib23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/PL00005314","article-title":"Dopamine D3 receptor activation modulates renal function in anesthetized rats","volume":"358","author":"Luippold","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.115.224121_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00210-005-0020-7","article-title":"Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice","volume":"372","author":"Luippold","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.115.224121_bib25","first-page":"5","article-title":"D3 receptor binding in human brain during cocaine overdose","volume":"2","author":"Mash","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.115.224121_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/jm901319p","article-title":"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists","volume":"53","author":"Micheli","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.115.224121_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/157488906778773634","article-title":"Selective dopamine D3 receptor antagonists: a review 2001-2005","volume":"1","author":"Micheli","year":"2006","journal-title":"Recent Patents CNS Drug Discov"},{"key":"10.1124\/jpet.115.224121_bib28","series-title":"Analysis of Messy Data, Vol 1: Designed Experiments","author":"Milliken","year":"1992"},{"key":"10.1124\/jpet.115.224121_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/npp.2012.171","article-title":"Occupancy of brain dopamine D3 receptors and drug craving: a translational approach","volume":"38","author":"Mugnaini","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.115.224121_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/npp.2013.192","article-title":"Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO","volume":"39","author":"Payer","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.115.224121_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.neuropharm.2008.12.007","article-title":"The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats","volume":"56","author":"Peng","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.224121_bib33","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bjp.2008.280","article-title":"Principles of safety pharmacology","volume":"154","author":"Pugsley","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.224121_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/syn.20983","article-title":"The acute administration of the selective dopamine D(3) receptor antagonist SB-277011A reverses conditioned place aversion produced by naloxone precipitated withdrawal from acute morphine administration in rats","volume":"66","author":"Rice","year":"2012","journal-title":"Synapse"},{"key":"10.1124\/jpet.115.224121_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2010.04.038","article-title":"Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist","volume":"68","author":"Searle","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.115.224121_bib36","series-title":"Biometry: The Principles and Practice of Statistics in Biological Research","author":"Sokal","year":"1981"},{"key":"10.1124\/jpet.115.224121_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1124\/jpet.115.224121_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1369-1600.2011.00317.x","article-title":"YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice","volume":"17","author":"Song","year":"2012","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.115.224121_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2013.10.010","article-title":"Blockade of D3 receptors by YQA14 inhibits cocaine\u2019s rewarding effects and relapse to drug-seeking behavior in rats","volume":"77","author":"Song","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.115.224121_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.06.041","article-title":"Cocaine use and risk of stroke: a systematic review","volume":"142","author":"Sordo","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.115.224121_bib41","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","article-title":"Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities","volume":"16","author":"Staley","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.115.224121_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0361-9230(82)90145-9","article-title":"The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat","volume":"9","author":"Swanson","year":"1982","journal-title":"Brain Res Bull"},{"key":"10.1124\/jpet.115.224121_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0269881111431750","article-title":"Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state","volume":"26","author":"te Beek","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.115.224121_bib44","series-title":"Guidance for Industry S7A Safety Pharmacology Studies for Human Pharmaceuticals","year":"2001"},{"key":"10.1124\/jpet.115.224121_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"J Pharmacol Methods"},{"key":"10.1124\/jpet.115.224121_bib46","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.22-21-09595.2002","article-title":"Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats","volume":"22","author":"Vorel","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.115.224121_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2014.06.006","article-title":"The heterogeneity of ventral tegmental area neurons: Projection functions in a mood-related context","volume":"282C","author":"Walsh","year":"2014","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.115.224121_bib48","first-page":"445","article-title":"Brain mechanisms of drug reward and euphoria","volume":"3","author":"Wise","year":"1985","journal-title":"Psychiatr Med"},{"key":"10.1124\/jpet.115.224121_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1527-3458.2007.00013.x","article-title":"Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction","volume":"13","author":"Xi","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.115.224121_bib50","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1460-9568.2005.04159.x","article-title":"Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats","volume":"21","author":"Xi","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.115.224121_bib51","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ajh.2009.80","article-title":"D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs","volume":"22","author":"Yu","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1124\/jpet.115.224121_bib52","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/ki.2008.247","article-title":"Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions","volume":"74","author":"Zeng","year":"2008","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.115.224121_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1152\/physiolgenomics.00127.2004","article-title":"Functional genomics of the dopaminergic system in hypertension","volume":"19","author":"Zeng","year":"2004","journal-title":"Physiol Genomics"},{"key":"10.1124\/jpet.115.224121_bib54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccc.2012.07.003","article-title":"Cocaine intoxication","volume":"28","author":"Zimmerman","year":"2012","journal-title":"Crit Care Clin"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524191033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.224121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:35:31Z","timestamp":1739993731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524191033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022356524191033"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.224121","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.224121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}